Product Program year 2019 Source: CMS Open Payments

Sylvant

Biological Hematology Oncology

NDC 57894-420-01

Open in the dashboard

General payments

$232,724

919 payments

Research payments

$0

0 payments

Through program year 2019, $232,724 in general payments and $0 in research payments were reported against Sylvant (Hematology Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $232,724 919

Breakdown

Who paid General payments · program year 2019
  1. EUSA Pharma (US) LLC $232,724 919 payments
Top recipients General payments · program year 2019
  1. Gordon Srkalovic Hematology & Oncology · Lansing, MI $34,383 15% · 39 payments
  2. Ahmed Galal Hematology · Morristown, NJ $22,145 10% · 30 payments
  3. Mingyi Chen Hematology · Dallas, TX $16,868 7% · 42 payments
  4. Corey Casper Infectious Disease · Seattle, WA $16,635 7% · 34 payments
  5. Jadee Neff Hematology · Durham, NC $15,021 6% · 29 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Hematology & Oncology Internal Medicine $81,580 36% · 228 practitioners
  2. Hematology Internal Medicine $39,044 17% · 19 practitioners
  3. Hematology Pathology $31,889 14% · 2 practitioners
  4. Anatomic Pathology & Clinical Pathology Pathology $23,612 10% · 8 practitioners
  5. Infectious Disease Internal Medicine $16,647 7% · 2 practitioners

The top 5 of 39 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Michigan $34,475 15% · 6 recipients
  2. Texas $30,134 13% · 35 recipients
  3. California $26,500 11% · 92 recipients
  4. South Dakota $22,145 10% · 1 recipient
  5. Arkansas $16,833 7% · 3 recipients

The top 5 of 35 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

919 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record